Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study is a research paper published in medRxiv (2020). On theSindex it has a DataRank of 0. It has been cited 133 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Versus Arthritis
Grant: 21605
UK Research and Innovation
Grant: MR/K501256/1
DTG 2013 & 2014
European Commission
Grant: 806968
European Health Data and Evidence Network
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study
Additional file 1 of Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study